baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

INCYTE DL-,001/ US45337C1027 /

10/01/2025 08:05:53	Chg. +0.120	Volume	Bid12:43:13	Ask12:43:13	Market Capitalization	Dividend Y.	P/E Ratio
70.680EUR	+0.17%	- Turnover: -	70.680Bid Size: 300	71.300Ask Size: 300	13.61 bill.EUR	-	-

Newsfile Corp 22/11/2024 SEC Announces Enforcement Results for Fiscal Year 2024

TeleTrader 19/11/2024 US opens sharply lower as geopolitics weigh on markets

GlobeNewswire 27/08/2024 Alex Bastian joins Memo Therapeutics AG as VP Commercial Strategy

GlobeNewswire 16/08/2024 China Medical System （00867） Released its 2024 Interim Results: Steady Increase in Revenue and Profi...

GlobeNewswire 06/08/2024 MacroGenics Provides Update on Corporate Progress, Second Quarter 2024 Financial Results

GlobeNewswire 01/08/2024 Merus Announces Financial Results for the Second Quarter 2024 and Provides Business Update

GlobeNewswire 30/07/2024 MacroGenics Announces Achievement of $100 Million in Milestones Related to Retifanlimab Collaboratio...

Newsfile Corp 17/07/2024 Analysts Hunt for Undervalued Biotech Stocks

TeleTrader 09/07/2024 US closes mostly higher after Fed's chair testimony

GlobeNewswire 25/06/2024 China Medical System Completes Dosing of the First Subject in Phase III Bridging Trial of Ruxolitini...

GlobeNewswire 29/05/2024 Lynch Carpenter Investigates Claims in Cencora, Inc. Data Breach

GlobeNewswire 28/05/2024 Keros Therapeutics Appoints Jean-Jacques Bienaimé to its Board of Directors

GlobeNewswire 09/05/2024 MacroGenics Provides Update on Corporate Progress, First Quarter 2024 Financial Results and Interim ...

GlobeNewswire 08/05/2024 Merus Announces Financial Results for the First Quarter 2024 and Provides Business Update

GlobeNewswire 30/04/2024 Akero Therapeutics Appoints Scott Gangloff as Chief Technology Officer

GlobeNewswire 02/04/2024 HUTCHMED and Innovent Jointly Announce NDA Acceptance in China for Fruquintinib Combination with Sin...

GlobeNewswire 01/04/2024 CMS and Incyte Announce Collaboration and License Agreement for Povorcitinib in China and Southeast ...

GlobeNewswire 28/02/2024 Merus Announces Financial Results for the Fourth Quarter and Full Year 2023 and Provides Business Up...

GlobeNewswire 09/01/2024 Global Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030

TeleTrader 12/12/2023 Wall Street closes higher after inflation report

GlobeNewswire 09/12/2023 CURE Media Group announces winners of the 2023 MPN Heroes® Recognition Program

GlobeNewswire 16/11/2023 CURE Media Group® announces Jane Fonda as keynote speaker for the 2023 MPN Heroes® recognition progr...

GlobeNewswire 02/11/2023 Merus Announces Financial Results for the Third Quarter 2023 and Provides Business Update

GlobeNewswire 23/10/2023 Elevar Therapeutics Names Brian Cunningham Vice President of Sales and Kenneth Rankin Vice President...

INCYTE DL-,001/ US45337C1027 /

If you wish to receive reply to your feedback, please provide your email address.